SCHEMBL4692587

SCHEMBL4692587

CCC(CC)CNC[C@@H](O)[C@@H](N)Cc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1E P49674 1/20 0.52
TRPA1 O75762 1/20 0.46
F2 P00734 2/20 0.45
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
EPHX1 P07099 1/20 0.43
BCHE P06276 2/20 0.43
LAP3 P28838 3/20 0.41
ANPEP P15144 1/20 0.41
RNPEP Q9H4A4 1/20 0.41
DNPEP Q9ULA0 1/20 0.41
SLC6A2 P23975 2/20 0.41
TAAR1 Q96RJ0 2/20 0.41
MAOA P21397 1/20 0.41
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
CYP2A6 P11509 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7300383 0.89 CSNK1E (0.54) CSNK1EF2EPHX1BCHELAP3
SCHEMBL3351744 0.88 CSNK1E (0.52) CSNK1ETRPA1F2EPHX1BCHE
Hydrochloric Acid SCHEMBL7310009 0.87 CSNK1E (0.53) CSNK1EF2EPHX1BCHELAP3
SCHEMBL3355611 0.86 CSNK1E (0.56) CSNK1ETRPA1F2EPHX1BCHE
Hydrochloric Acid SCHEMBL5218959 0.84 CSNK1E (0.55) CSNK1ETRPA1F2EPHX1BCHE
SCHEMBL1286637 0.84 CSNK1E (0.51) CSNK1ETRPA1F2EPHX1BCHE
SCHEMBL6895260 0.84 CSNK1E (0.51) CSNK1ETRPA1F2ALDH1A1EPHX1
SCHEMBL3358249 0.84 CSNK1E (0.51) CSNK1ETRPA1F2ALDH1A1EPHX1
SCHEMBL1286638 0.84 CSNK1E (0.51) CSNK1ETRPA1F2EPHX1BCHE
SCHEMBL1057036 0.84 CSNK1E (0.51) CSNK1ETRPA1F2EPHX1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1692143-B1 TRICYCLIC INDOLE HYDROXYETHYLAMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2008-11-12 EP disclosed